The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort to create global awareness of the disease that’s so rare that fewer than 200,000 new cases are diagnosed each year.…...
VF Funds $160,000 in New Research
The VF Board of Directors is pleased to announce it has selected three new research studies for funding in 2018. The studies were chosen from a selection of 20 applications submitted by investigators world-wide. Every year the VF receives proposals for very high-quality research from investigators who have a wealth…...
Nucala Approved for EGPA/CSS Treatment
GlaxoSmithKline (GSK) achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US December 13, 2017: GSK announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known…...
Introducing our 2017-2018 VCRC-VF Fellow
Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship. She received her medical degree from New York Medical College in Valhalla, New York. She completed her Internal Medicine residency and a two-year Rheumatology fellowship training program at MedStar Georgetown University Hospital in Washington, D.C. Dr. Quinn is currently…...
